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1. Introduction
Environmental monitoring is a critical mission of the U. S. Army Corps of Engineers due to its
commitment to support not only the soldiers, but also to maintain the environment on military
lands and installations. The detection of contaminants present in the environment, specifically
water resources, is vital to ensure the safety of soldiers at forward base locations and to promote
the sustainable usage of military lands. Therefore, fieldable, robust, and sensitive detection
mechanisms are required for screening applications that provide rapid environmental
assessment. Typically, sensor and detector research focuses on new techniques and methods
to characterize a sample for an analyte of interest. A metric that must be satisfied for success
is the selectivity of the sensor, i.e., how well it can measure only a particular analyte without
response to other closely related chemicals. Under certain conditions, it makes sense to use
sensors with specificity. However, a quantitative result alone does not translate easily to a
measure of toxicity to the soldier or to an assessment of environmental impact. Further, the
uncertainties inherent to unfamiliar and frequently hostile environments preclude exact
knowledge of a complete set of potential analytes.
Our Biomimetic Sensor for Rapid Testing of Water Resources program at the Construction
Engineering Research Laboratory (ERDC-CERL) was initiated precisely to investigate and
advance aspects of miniaturized microfluidic devices for toxicity sensing. This work package
represents a change in the sensor and detector paradigm typical of legacy Corps of Engineer
analytical research. Providing the soldier in the military environment with a rapid, universal
indicator of a chemical threat may prove more powerful and vital than identifying what
compound is present. Our goal in this program was to assess the property of overall toxicity,
rather than acquisition of a compendium of individual chemical concentrations. The chosen
way to acquire this property was to expose the water sample of interest to a population of
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living cells where we ascertain the harmful impact of the sample on cellular metabolism,
function and communication.
Most commercially available rapid toxicity screening test kits use luminescent bacteria,
photosynthetic algae, or plant enzymes to monitor toxicity via luminescence or colorimetric
assay, which report a decrease in cellular respiration or enzyme turnover in relation to the
toxicity of the test sample (http://www.epa.gov/nrmrl/std/etv/vt-ams.html#rtts). From a
soldier health perspective, however, the use of mammalian (human) cell-based biosensors for
rapid risk assessments would be more beneficial due to the direct correlation of the toxicity
data to the human health effects on the soldiers. Therefore, many of the sensing mechanisms
we are developing integrate more biorelevant cells for specific major organ systems into the
sensing platform. Further, we maintain a more ambitious goal to move beyond homogeneous
cell culture to an intelligently designed heterogeneous population of multiple cell types that
recapitulates in vivo tissue function. Depending on the final application however, these same
sensor platforms could be populated with fish and animal cells/tissues when direct environ‐
mental impact analyses are required on particular strata of an ecosystem.
Cell-based biosensors utilize immobilized living cells (either prokaryote or eukaryote) as the
biorecognition element. The impact of the chemical stimulus on the cell generates changes to
the intracellular or extracellular biochemistry that are most frequently detected either electri‐
cally or optically [1, 2]. While the cellular response may require an incubation time with the
contaminant that increases total analysis time, the ability of cells to respond to minute changes
in their complex environment imbues cell-based biosensors with high sensitivity and more
importantly for our task, biorelevance. Also, the ability of the biosensor to report the bioavail‐
ability of a compound may be more critical than the analytical determination that the com‐
pound is present. Unlike some current biorecognition based sensors that utilize antibodies,
aptamers, or other analyte-specific binding mechanisms, biosensors incorporating intact living
cells can respond to emerging or little known chemical or biological threats and can be engaged
as broad spectrum screening tools [1]. Finally, by exploiting the biochemical response of the
living cell to the entire complex composition of a water sample, we can ascertain additive and
synergistic effects impossible to discern using a suite of selective sensors.
Despite the advantages of using cell-based biosensors, there are non-trivial obstacles to
consider when incorporating living cells onto a device to be used in austere environments.
Perturbations in temperature, pH, oxygen/carbon dioxide levels, nutrients, and sterility can
all have deleterious effects on the survivability of the cell population thus rendering the
biosensor less reliable or simply unusable. Therefore, maintaining a well-defined and healthy
cell population with adequate controls presents the most difficult challenge for the develop‐
ment and wide spread usage of cell-based biosensors.
Recognizing these hurdles, we formed a collaborative research effort that aimed to create
sensors that instantly alert personnel to a toxic threat in water by designing, building, and
testing microfluidic devices that accurately replicate the physiological response of an organ
structure to contaminants in water. We are developing both electrical and optical transduction
methods for the detection and translation of the cell’s physiological response to a water
toxicant. The ultimate goal of the project was the development of a microfluidic platform that
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housed a complete set of three-dimensional (3D) “organs” reconstructed from heterogeneous
cell/tissue populations that worked in a physiologically realistic manner to represent the
circulatory pattern of an entire organism (e.g., human). With the understanding that recapit‐
ulating a truly physiologically accurate “body on a chip” is a momentous task, we have focused
our research efforts to develop tools, technology and scientific knowledge that bring us closer
to this vision. This chapter describes several of the resultant scientific collaborations with
academic partners in this biomimetic sensor program.
A class of in vitro tissue models known as micro-cell culture analogs (μCCAs) has been
developed by pioneering research in the laboratory of Dr. Michael Shuler at Cornell University
[3-5]. Micro-CCAs are composed of a microfluidic platform that allows multiple “organs” to
be combined in a physiologically realistic manner. Such a device is a tangible representation
of a physiologically based pharmacokinetic (PBPK) model that translates in vivo conditions
such as liquid to cell ratios, fluid residence times, and physiological shear stress that are
realistic to each organ type into parameters that can be integrated into a microfluidic device
through microfabrication. Therefore, each organ is recreated on the chip with cells housed in
a precisely designed organ chamber [6] (Figure 1). The evolutionary design of the μCCA has
increased from three chambers [5], to four chambers [7] and includes more complex organs
and tissue types such as fat cells, which may alter the response [8]. Additionally, one of the
main routes of toxicant introduction into the body is through oral ingestion and subsequent
absorption from the gastrointestinal (GI) system, which represents first pass metabolism.
Therefore, a critical component to the μCCA was the inclusion of the GI system mimic (Figure
2). We have developed a GI module that incorporates a mixture of cell types to better mimic
realistic intestinal cell populations, which include absorptive enterocytes and mucus produc‐
ing goblet-like cells [9-11]. The mixture of cells is cultured on a microporous membrane to
allow introduction of the analyte of interest at the apical side, but limits passage to the
basolateral side to only those analytes that successfully pass through the functional GI cell
barrier layer (Figure 2C). For total system recirculation, a peristaltic pump is used with tubing
connecting the analyte source and the apical GI surface (for continuous “ingestion”), and the
basolateral GI surface is connected to the μCCA body chip (Figure 2A and 2B). Devices such
as these are valuable not only as tools for toxicity screening but also as tools for screening drug
candidates, indicating drug efficacies and side effects as well as combinatorial effects from
mixtures of compounds, thus lessening the dependence on animal models.
Figure 1. Micro-CCA device with fabricated organ chambers. Image provided by M. Shuler.
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Figure 2. (A) Image of the systemic µCCA. Organ chambers and channels are fabricated to accurately scale the cham‐
ber size and the interconnecting channels so they are representative of in vivo circulating conditions for those organs.
The other tissues of the body were represented by the external de-bubbler, which was a 200 µL reservoir. (B) Image of
the systemic and GI tract µCCA experimental set-up. (C) The GI module housed in a plexiglass chamber with cells seed‐
ed on a semiporous membrane. Images provided by M. Shuler.
2. Electrochemical detection methods for cellular stress biomarkers
One type of cellular response to a toxicant is through the generation of extracellular biomark‐
ers. In this manner, we can transform a toxicity response to a contaminant suite into a bio‐
marker concentration. The main focus of our collaboration with Dr. Scott Banta at Columbia
University is the generation of a streamlined platform for the rapid development of new
biosensors that can be used to detect virtually any desired protein biomarker target. The overall
selectivity and sensitivity of the biosensor are dependent not only on the recognition element,
but also on the transducer used to detect the response. Therefore, our research combines
generation of novel biorecognition elements with electrochemical transduction to fabricate
powerful selective sensing modalities [12].
The process we have developed includes: biomarker (target) selection and immobilization,
phage display to select binding peptides, peptide synthesis with a terminal thiol, quartz crystal
microbalance (QCM) for in-situ monitoring of peptide immobilization, and analyte detection
using electrochemical techniques (Figure 3A). Target selection involves several rounds of M13
phage display followed by enrichment of short unstructured peptides that bind to the desired
target with increased affinity. For the sensor performance, the selected, final round peptides
are chemically synthesized and immobilized on a gold surface, allowing for detection of the
target using QCM (Figure 3B) or electrochemical impedance spectroscopy (EIS) (Figure 3C).
The use of short unstructured peptides over more complex protein-based affinity scaffolds has
several advantages: 1) peptides are stable and resistant to harsh environments, 2) peptides can
be synthesized easily and inexpensively, and 3) peptides can be more amenable than antibodies
to engineering at the molecular level due to their smaller size. In addition, peptide immobili‐
zation on gold electrodes has been well established.
We demonstrated the utility of this approach by creating a novel peptide-based electrochem‐
ical biosensor for the enzymes alanine transaminase (ALT), a well known biomarker of
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hepatotoxicity. The sensor was prepared using the selected ALT peptide that had been
modified with a C-terminal cysteine to facilitate the immobilization on a gold surface. Once
the peptide had been immobilized, any remaining bare gold was blocked by the addition of
free cysteine to prevent non-specific binding of the target directly to the gold surface. The
binding and blocking processes were monitored by QCM, cyclic voltammetry (CV) and EIS.
The peptide immobilization resulted in a frequency drop in the QCM signal due to the
increased mass loading, a drop in current was detectable by CV, and an impedance increase
in the EIS due to the blocking of the gold surface. The packing density of the surface-bound
peptide can be calculated using the Sauerbrey equation [13]:
 m ff C x mD = - D (1)
where Δfm is the frequency change due to mass loading, Δm is the mass change at the QCM
crystal surface and Cf = 0.0566 Hz/(ng/cm2) for a 5 MHz AT-cut crystal at 20°C. The frequency
drop of the QCM due to the immobilization of the peptide was roughly 21 Hz, which correlates
to a packing density of 2x10-10 mol/cm2 or 1.2x1014 molecule/cm2 using a peptide molecular
weight of 1851 g/mol.
Next QCM, CV and EIS were used to demonstrate the affinity and specificity of the immobi‐
lized peptide for ALT (Figures 4 and 5). A frequency drop (Df = -31 Hz) in QCM was observed
upon binding of ALT versus the frequency of the sensor in buffer alone (Figure 4A). A current
decrease in CV (Figure 4B) as well as a large impedance increase (Figure 4C) was measured
upon addition of ALT, while buffer alone resulted in no change.
Figure 5 shows the specificity of the peptide (Au-Peptide) for ALT over streptavidin (SA) or
bovine serum albumin (BSA). The greatest frequency change of -31 Hz was observed with
ALT. Although a small frequency change (about -3 Hz) was seen with SA and BSA, this change
may be due to a small amount of non-specific binding of the proteins to unoccupied sites on
the surface or non-specific interactions with the peptide itself.
Figure 3. Schematic diagram illustrating the general process of biosensor development. (A) Work flow diagram for
biosensor development: 1. Target protein biomarker selection, 2. Phage display selection, 3. Peptide synthesis, 4. QCM
diagnosis, 5. Biomarker detection. B) The basic principle of QCM where the binding of the target protein to the immo‐
bilized peptides causes a frequency change in the oscillation of the quartz crystal. C) The basic principle of EIS where
the binding of the target protein to the immobilized peptides causes increased resistance to the reaction of an added
redox couple.
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Figure 5. Specificity of the ALT biosensor. The shift in QCM frequency in response to injections of SA, BSA or ALT on
the Au-Peptide modified crystal. The concentrations of all three solutions were 10 µg/mL.
For quantitative measurements, CV was not performed due to the limited detection range since
the current decreases upon target binding. Therefore, we performed only QCM and EIS using
a range of ALT concentrations (Figure 6). A quantitative response was observed for both QCM
(Figure 6A) and EIS (Figure 6B) for the range of ALT concentrations tested. The LOD obtained
by QCM is 60 ng/mL, while EIS has a LOD of 92 ng/mL. The sensitivity of the QCM system
was 8.9 +/- 0.9 Hz/(mg/mL), while the sensitivity of the EIS system was 142 +/- 12 impedance
percentage change %/(mg/mL). The quantitative response achieved for both QCM and EIS
validates that both methods could be used as a sensing technique in quantitative ALT
measurements.
Figure 4. Sensor operation. A) QCM frequency change of Au-Peptide electrode in Buffer alone and in 10 mg/mL ALT,
B) CV of Au-Peptide electrode before (Baseline) and after Buffer alone or ALT binding, C) EIS of Au-Peptide before
(Baseline) and after Buffer alone or ALT binding. After incubation in Buffer or 10 mg/mL ALT, the electrodes were
transferred to 1 mM solution of Fe(CN)64-/3- in 0.1 M NaClO4 for the EIS measurements.
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Figure 6. Response curves of ALT binding. Measurements were made using QCM (shown as absolute value of fre‐
quency change) (A) and EIS (B). Each run was performed using a single electrode with successive tests in ALT solutions
from low to high concentration. The apparent amount of bound ALT (NALT) for the QCM measurements was calculated
using Eqn. 1 and is shown on the right ordinate. Error bars represent standard deviations obtained from triplicate
measurements.
In addition to the generation of this ALT-specific recognition element, we have developed a
recognition element for the cardiac specific biomarker, troponin I (TnI) [13, 14]. Again, phage
display was employed to generate the recognition peptide while QCM and EIS validated and
quantified the binding events and specificity of the peptide for the target, TnI. Therefore, the
generation of a peptide recognition element specific for the binding of either ALT or TnI
followed by immobilization onto a gold surface for signal transduction supports this method
of biorecognition element generation for the detection of any specific cellular stress biomarker.
The recognition peptide provides the next step toward increasing stability over antibodies, but
quantitative impact versus longevity depends upon how it is used in a more mature device.
We are currently engaged in transitioning the peptide recognition schemes onto a fieldable
chip. Reuse conditions for the chip must also be investigated but likely involves introduction
of a release buffer with glycine-HCl.
We recognize that gold components within microfluidic devices, specifically as electrode
materials, are prone to biofouling. In an effort to use an electrode material both more resistant
to biofouling and possessing a larger potential range compared to noble metal electrodes
[15-17], we developed a new method for the fabrication of carbon paste electrodes (CPEs) that
optimizes their stability in a flow-based microfluidic device [18]. The greater stability of these
CPEs results from exploiting beneficial properties of both soft and rigid composites, which are
used as the binder, during CPE fabrication. As a result of our collaboration with Dr. Charles
Henry at Colorado State University, we have developed a mixed binder to create on-chip CPEs
for flow-based devices. The mixed binder composed of a soft composite (mineral oil) and a
rigid composite (poly(dimethylsiloxane) (PDMS)) enhanced the overall CPE robustness and
electrochemistry over that of a CPE fabricated with mineral oil or PDMS alone. Analysis of the
CPE performance was carried out using cyclic voltammetry in static solutions or amperometry
with flow injection analysis.
The CPEs are fabricated simply by filling channels molded in previously cross-linked PDMS
using a method analogous to screen printing with the CPE mixture, which is composed of
Biomimetic Sensors for Rapid Testing of Water Resources
http://dx.doi.org/10.5772/52438
35
graphite powder and the PDMS:mineral oil binder (Figure 7). Further, we demonstrated that
the PDMS: mineral oil CPEs can easily be chemically modified for the detection of biologically
relevant molecules. The monitoring of thiols provides an indication of the functioning of
numerous critical cellular pathways [19, 20]. Traditional carbon paste electrodes can be used
to detect thiols, however, they suffer from low peak currents due to poor interactions between
the carbon and the thiols. Therefore, we added the electrocatalytic reagent cobalt phthalocya‐
nine (CoPC), which is widely used as a reduction/oxidation mediator for lowering the
overpotential of thiols [21-23], to decrease decrease the detection potential and increase the
peak current obtainable with carbon electrodes. The model analyte dithiothreitol (DTT) was
used to demonstrate the sensitivity of the CoPC modified CPEs for the detection of thiols.
Cyclic voltammetry and amperometry were used to compare the CoPC modified CPEs to bare
CPEs (Figure 8). The detectable electrocatalytic process occurs in two steps that involve the
initial electrochemical oxidation of Co(II)phthalocyanine followed by the chemical oxidation
of DTT as it regenerates the Co(II)phthalocyanine [23]. Figure 8A shows the cyclic voltammo‐
grams of a CoPC modified CPE (solid line) versus an unmodified CPE (dashed line) of 1 mM
DTT in MES buffer (2-(N-morpholino)ethanesulfonic acid, 30 mM, pH 7.4). Under these
conditions, the unmodified CPE failed to detect the DTT whereas the expected oxidation peak
of DTT was observed for the CoPC modified CPE [24]. We evaluated the performance of the
CPEs for DTT detection with respect to the amount of CoPC added to the graphite and
determined that a mixture of 12% CoPC in graphite performed the best (data not shown). Also,
the composition of the binder was investigated to identify the best DTT detection performance,
and the ratio of 2:3 PDMS:mineral oil was optimal to maintain robustness and electrochemical
performance. The secondary means to characterize the performance of the CoPC modified
CPEs involved flow injection analysis using amperometric detection for the continuous
detection of DTT (Figure 8B). Using a CoPC modified electrode, we observed nearly a 2-fold
improvement in the electrochemical signal (4.0 ± 0.2 nA (n = 3) versus 2.5 ± 0.2 nA (n = 3)) for
a bare CPE for 100 μM DTT. Additionally, the limit of detection (LOD, defined as the concen‐
tration yielding a 3x larger signal than baseline noise) for DTT with a CoPC modified CPE was
2.5 ± 0.2 μM (n = 5) versus 16.8 μM (n = 5) for an unmodified CPE.
Figure 7. Flow-based microfluidic system using CPEs. (A) Schematic for electrode fabrication process (side view), (B)
Photogragh of electrode alignment in a microfluidic device for the flow injection system with amperometric detection
(top) and for cyclic voltammetry study (bottom). Size of electrodes: 250 µm wide and 50 µm deep. Electrode spacing
(center-to-center), 300 µm. Microfluidic channel dimension: 250 µm wide, 50 µm deep and 2.5 cm long. Reproduced
by permission of The Royal Society of Chemistry.
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Figure 8. Comparison of working electrode performance for DTT detection between CoPC modified CPE (solid line)
and unmodified CPE (dashed line). (A) Cyclic voltammograms of 1 mM DTT in 30 mM MES buffer, pH 7. (B) Flow injec‐
tion analysis with amperometric detection of 100 µM DTT using 30 mM MES, pH 7, as a running buffer. Paste composi‐
tion ratio is 5 : 3 : 2 (graphite:oil:PDMS). Off-chip reference and auxiliary electrodes were used. Applied potential: 0.2 V
(vs. Ag/AgCl (3 M KCl)) for both types of working electrodes with Pt wire as an auxiliary electrode. Flow rate: 60 mL
min-1. Reproduced by permission of The Royal Society of Chemistry.
Next, we chemically modified the CPEs with multi-walled carbon nanotubes (MWCNT) for the
detection of catecholamines.  The importance of the ability to detect  biologically relevant
compounds from cells is critical not only for our current application of detection of toxic
compounds in the environment, but also for the detection or monitoring of debilitating diseases.
Catecholamines like dopamine are known to be involved in the progression of neurological
diseases such as Parkinson’s and Alzheimer’s [25, 26]. Using the MWCNT modified CPEs, we
were able to detect the release of dopamine from cultured rat PC12 cells. The data for the flow
injection analysis for the detection of 10 μM dopamine is shown in Figure 9 using both MWCNT
modified (solid line) and unmodified (dashed line) CPEs. A more significant improvement in
signal was observed for the MWCNT modified CPEs when detecting catecholamines, namely
dopamine, than shown above for DTT. We determined that the lowest dopamine concentra‐
tion detectable by MWCNT modified CPEs was 50 nM whereas concentrations below 500 nM
for unmodified CPEs were undetectable. This order of magnitude increase in detection likely
results from the increased surface area of the electrode achieved with the addition of the
MWCNTs and therefore, the peak currents obtained for the CPEs.
We also observed the release of catecholamines from PC12 cells upon exposure to high
concentrations of potassium. At each time point, the catecholamine released was measured
from potassium-stimulated PC12 cells (6 x 104 cells/time point) using the flow injection analysis
system with MWCNT modified CPEs. Figure 10 shows the plot of the peak area versus time
for the duration of potassium exposure. At three minutes, the calculated concentration of
released catecholamine was estimated to be 3.6 μM (58.3 pM/cell). Concentrations of catechol‐
amine released by PC12 cells upon exocytotic events have been reported to be 67 μM [27, 28]
or 20-160 μM dopamine from 1.3 x 104 cells exposed to calcium stimulation [29]. The lower
levels of catecholamines detected by our system may be the result of very low capture efficiency
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of this non-optimized CPE design. Interestingly, it is likely that neuronal cells, like PC12s, have
a process to re-uptake catecholamines, and this common theory is supported by the sharp
decrease in catecholamine signal we observed with our MWCNT modified CPE system at time
points after the significant release that occurs at three minutes.
Figure 10. Effect of potassium on catecholamine release from PC12 cells. 6.15 x 104 cells were stimulated at each time
point. Supernatant was removed and stored on ice until analysis. All experimental conditions same as in Fig. 9. Repro‐
duced by permission of The Royal Society of Chemistry.
The ability to determine the biological consequences of known and unknown toxicants is
essential for the protection of the environment and soldier health. We have generated a novel
approach for the development of carbon paste electrodes that are integrated, robust, and low
cost for microfluidic detection of extracellular biomarkers [18]. Figs 8B and 9 show that the
CPEs are stable and reusable over many cycles, although the exact number of cycles depends
upon the sample matrix and the run conditions. The CPEs can be readily modified to monitor
biologically informative species, which can indicate the cellular responses to environmental
stimuli. With its simple modification scheme to introduce electrode selectivity and its intricate
design capability allowing for detailed electrode features, this biosensing system can be easily
incorporated into many detection platforms.
3. Cell-based sensor designs
We have developed a simple and direct in vitro method to control the alignment and elongation
of cells in order to form self-organized 3D tissues as part of a collaborative effort with Dr. Ali
Figure 9. Flow injection analysis of dopamine. Comparison of unmodified CPE (dashed line) and MWCNT modified
CPE (solid line). Sequential injections of 10 µM dopamine. Off-chip reference and auxiliary electrodes were used. Ap‐
plied potential: 0.6 V (vs. Ag/AgCl (3M KCl)) with Pt wire as an auxiliary electrode. Flow rate: 60 mL min-1. Reproduced
by permission of The Royal Society of Chemistry.
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Khademhosseini’s laboratory at Harvard University. By harnessing the intrinsic potential of
certain cells to form aligned tissues in vivo, we can generate functional tissues in vitro by
confining the cells in the appropriate 3D microarchitecture [30]. Cells possessing the prereq‐
uisite ability to self-organize in vivo include fibroblasts, myoblasts, endothelial cells, and
cardiac stem cells. The process involves embedding the cells in microengineered 3D gelatin
methacrylate (GelMA) hydrogels, which are micropatterned into high aspect ratio rectangular
constructs. In contrast, the cellular alignment in unpatterned microconstructs remained
random. By precisely controlling this microgeometry, we can induce the controlled cellular
alignment and elongation throughout the entire engineered construct in a user-defined
manner. We envision this technology to enable the construction of engineered functional 3D
tissues with aligned cells and anisotropic function. Additionally, we extended this technology
for the development of a cell-based biosensor for the detection of cardiotoxicity in real-time
by following changes in cardiomyocyte beating properties [31].
To demonstrate the control of cellular alignment and elongation properties in vitro, we encapsu‐
lated 3T3-fibroblasts (10 x 106 cell/mL) in a GelMA construct (800 μm (l) x 150 μm (h) x 50 μm
(w)). A 1 mm border surrounded the multiple parallel microconstructs to serve as an unpat‐
terned control (Figure 11). The GelMA macromer concentration (5% w/v, ~80% methacryla‐
tion degree) was chosen to maintain the mechanical stiffness but still preserve cell viability and
allow the micropatterning of the intricate cell-laden features. After 1 day, elongation of the cells
was observed mainly along the edges of the micropatterns and followed the major axis of the
channel, but spread throughout the construct by 4-5 days. The lower series of panels illus‐
trates the lack of alignment within the unstructured GelMA. Additionally, the elongation and
alignment responses could be controlled by the cell density, hydrogel concentration, and culture
time (data not shown) further demonstrating the ability to fine tune these cellular properties.
Figure 11. Cell morphology and organization as a function of time in patterned and unpatterned microconstructs.
Patterning 3T3-fibroblast-laden 5% GelMA hydrogels into high aspect ratio rectangular microconstructs (50 µm (w) x
800 µm (l) x 150 µm (h)) induced cellular alignment and elongation, while cellular orientation in unpatterned hydro‐
gels remained random. (A) Rhodamine B stained GelMA hydrogel construct shows patterned and unpatterned re‐
gions. (B) Representative phase contrast images of 3T3-fibroblasts (10 x 106 cells/mL) encapsulated in patterned (top
row) and unpatterned regions of the GelMA hydrogel (bottom row) on days 1, 3 and 5 of culture show that elonga‐
tion increases over time for all hydrogels, while alignment is only induced in patterned constructs.
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We quantitatively analyzed the effects of microgeometry by patterning cells in GelMA
constructs with a standard length and height but varying widths (800 μm (l) x 150 μm (h) x
200, 100 or 50 μm (w)) (Figure 12). We observed a strong correlation between the ability of cells
to align and elongate throughout the construct with the decrease in width. Alignment was
assessed by counting cells whose nuclei were within 10° of the preferred nuclear orientation
as described [32]. Overall nuclear alignment and shape index were evaluated with NIH ImageJ
software to evaluate cell alignment and elongation [33, 34]. The narrowest microconstruct had
the best alignment with 64 ±8% of cells aligned (Figure 12A), and this increased to ~90% if the
preferred nuclear orientation was defined to within 20° (Figure 12F). That alignment percent‐
age decreased with increased channel width resulting in 40 ±6% for the 100 μm and 31 ±8% for
the 200 μm channels. However, compared to the unpatterned control, the 100 μm channel was
still statistically different (p < 0.01). The 200 μm channel was not statistically different and the
unpatterned control showed only 19 ±9% alignment to the construct (Figure 12A). In compar‐
ing the nuclear shape index (Figure 12B), the results were consistent with the lowest mean
nuclear shape index corresponding to the 50 μm wide rectangular microconstructs (0.807
±0.02). The 100 μm and 200 μm wide micropatterns displayed 0.869 ±0.03 and 0.917 ±0.02 mean
nuclear shape indices, respectively, while the unpatterned control had a mean nuclear shape
index of 0.923 ±0.03 (Figure 12B). Figures 12G-J show representative images of the unpatterned
and patterned microconstructs where increasing cell alignment and elongation is visible in
constructs of decreasing width.
Next, we expanded the number of cell types used for micropatterning to include additional,
self-organizing cells (human umbilical vein endothelial cells (HUVEC), rodent myoblasts
(C2C12), and rodent cardiac side population cells (CSP)) and non-organizing cells (Hep-G2)
to investigate the applicability of this technique to engineer a variety of tissues representative
of vascular system, skeletal muscle, and myocardial tissues, respectively (Figure 13). Accu‐
rately mimicking the in vivo microarchitecture of these systems would require highly elongat‐
ed, organized and aligned cell-ECM constructs. As a control, we selected a cell type that lacks
the intrinsic potential for self alignment in vivo or in vitro, human liver carcinoma cells (Hep-
G2). All cells were encapsulated in 5% (w/v) GelMA and micropatterned in 50 μm wide
rectangular microconstructs. After a five day culture time, the patterned and unpatterned cells
were stained with DAPI and phalloidin to visualize cell nuclei and F-actin, respectively (Figure
13A and B). Images revealed the HUVEC, C2C12, and CSP cells to be highly aligned, elongated,
and interconnected along the major axis of the micropatterned hydrogels. In contrast, the
unpatterned cells remained random with minimal nuclear organization observed only at the
edges of the hydrogel. Significant differences were observed upon quantitative analysis for
both cellular alignment and elongation (Figure 13C) as well as for mean nuclear shape index
(Figure 13D) for the HUVEC, C2C12 and CSP cells when comparing the patterned to unpat‐
terned constructs. Consistent with the lack of intrinsic potential, Hep-G2 cells did not show a
significant difference in observed alignment and elongation between the patterned and
unpatterned hydrogel constructs, but rather formed cell clusters of multiple cell nuclei
regardless of the aspect ratio of the microconstructs. Therefore, the in vivo ability of cells to
form aligned tissues is required to promote this alignment and elongation behavior in vitro via
specified microgeometry.
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In the quest to form a 3D tissue construct, we tested the ability of the self-assembly properties
of the microconstructs by generating a closely spaced rectangular array of cell-laden GelMA
hydrogels (Figure 14). We again used 3T3-fibroblasts embedded in 5% (w/v) GelMA patterned
into 50 μm wide microconstructs that were spaced 200 μm apart. After four days, the micro‐
constructs had merged in some sections along the channel (Figure 14A, red arrows). The
merging continued until day seven when the constructs had completely converged into a larger
macroscale tissue construct (~ 1cm2) (Figure 14B). F-actin staining of the macroscale tissue
revealed a fiber network that was aligned in one direction along the major axis of the micro‐
patterns and extended across the voids between the micropillars once the constructs fully
converged (Figure 14C).
Since a major goal of this research program is the development of portable devices that can
monitor toxicity, we applied the ability to form a 3D microengineered hydrogel for the
development of a cell-based biosensor capable of detecting cardiotoxicity using lens-free
imaging [31]. We have developed a cell-based biosensor that utilizes cardiomyocytes that are
imaged using a lens-free imaging technique with a complementary metal oxide semi-conduc‐
tor (CMOS) imaging module extracted from a standard webcam. The cardiomyocytes are
derived from mouse embryonic stem cells (ESCs) and tested for the changes in beating rates
Figure 12. Cell elongation and alignment as a function of microconstruct width. Decreasing the width of patterned
rectangular 5% GelMA microstructures (800 µm (l) x 150 µm (h)) increased 3T3-fibroblast alignment as well as nuclear
elongation after 5 days of culture. (A) Mean percentage of aligned cell nuclei (within 10° of preferred nuclear orienta‐
tion) shows 100 µm constructs were significantly more aligned than unpatterned controls, while 50 µm constructs
were significantly more aligned than all other groups. (B) Mean nuclear shape index (circularity = 4*π*area/perime‐
ter2) shows a similar pattern with 100 µm constructs having a significantly lower index than unpatterned controls,
while 50 µm constructs were significantly different than all other groups. (C), (D), (E) and (F) Histograms of the relative
alignment in 10° increments demonstrates increased cellular alignment with decreased microconstruct width. (G), (H),
(I) and (J) Representative phase contrast images of unpatterned, 200 µm, 100 µm and 50 µm wide microconstructs,
respectively, show significantly increased cell alignment and elongation inside the constructs with decreasing width.
(Error bars: ± SD; ***p < 0.001; **p < 0.01; *p < 0.01).
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and beat-to-beat variations upon exposure to known cardiotoxic compounds, isoprenaline and
doxorubicin. Figure 15 shows a schematic of the experimental setup with the CMOS module
positioned below the cardiomyocytes cultured in a commercially available chamber slide while
the white LED light source, controlled by a pinhole, is positioned over the cell culture. The
beating responses are monitored in real-time via an imaging processing program. Initial
characterization of the lens-free system prior to exposing the cardiomyocytes to any drugs
involved the cells being cultured in standard medium and the beating rates monitored
continually for 150 minutes (Figure 16). An average of 100 beats per minute was observed and
was consistent with literature reports [35, 36]. Only a 3% variation was measured in the beating
rates and indicated the cells displayed normal beating patterns.
In order to measure the chronotropic effects of a drug on our cardiomyocytes-based biosensor,
we selected two drugs with opposing effects: isoprenaline is a sympathomimetic β-adrenergic
agonist drug that can cause an abnormally increased heart rate (tachycardia) and doxorubicin
is an anti-cancer drug with side effects that can lead to an abnormally decreased heart rate
(bradycardia). In the case of isoprenaline, different concentrations (1, 5, 10, and 100 nM) were
dissolved in culture medium and added to the chamber slide. Measurements were collected
consecutively for 20s over a period of 1 min. Figure 17A shows the increases in relative beating
Figure 13. Cell elongation and alignment in multiple cell types. Patterning cell-laden 5% GelMA hydrogels into rec‐
tangular microconstructs (50 µm (w) x 800 µm (l) x 150 µm (h)) induced cellular alignment and elongation after 5 days
of culture only in cell types possessing an intrinsic potential to organize into aligned tissues in vivo, while cellular ori‐
entation in unpatterned parts of the same hydrogels remained random. Representative z-stack overlays of DAPI/F-ac‐
tin staining of (A) patterned and (B) unpatterned hydrogels laden with HUVEC, C2C12, CSP, and Hep-G2 cells
respectively show patterning induced aligned and elongated cell-network formations in HUVEC, C2C12 and CSP cells
and patterning independent cell-cluster formations in Hep-G2 cells. (C) Mean % of aligned cell nuclei (within 10° of
preferred orientation) shows patterned HUVEC-, C2C12- and CSP-laden constructs were significantly more aligned
than unpatterned controls, while in Hep-G2-laden constructs patterning failed to induce cell alignment. (D) Mean nu‐
clear shape index (circularity = 4*π*area/ perimeter2) similarly shows patterned HUVEC-, C2C12- and CSP-laden con‐
structs were significantly more elongated than unpatterned controls, while in Hep-G2-laden constructs patterning
failed to induce cell elongation. (Error bars: ± SD; **p < 0.01; ***p < 0.001)
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rates corresponding to the increase in isoprenaline concentration. After introduction of the
isoprenaline, the time interval between the beats became shorter and a new pulse pattern was
observed that indicated an increase in the beating rate (Figure 17B). Following a 12 min
exposure, the beating rates as a function of isoprenaline concentration were compared (Figure
17C). The beating rates increased 24% and 44% for 1 and 5 nM isoprenaline, respectively, and
70% for both 10 and 100 nM. This resulted in a statistical difference between 1, 5 and 10 nM,
but not between 10 and 100 nM. The patterns we observed are consistent with reported studies.
Figure 14. Self-assembly of multiple aligned microconstructs into a macroscale and aligned 3D tissue construct. 3T3-
fibroblast-laden 5% GelMA hydrogels patterned into rectangular microconstructs (50 µm (w) x 800 µm (l) x 150 µm
(h)) spaced 200 µm apart self-assembled into macroscale and aligned 3D tissue constructs after 7 days of culture
through convergence of multiple, aligned microconstructs. (A) Rhodamine B stained hydrogel shows initial microcon‐
struct spacing of 200 µm at day 0; representative phase contrast images of cell-laden microconstructs at days 1, 4 and
7, respectively, show focal points of contact between neighboring aligned microconstructs at day 4 (red arrows) and
formation of a macroscale 3D tissue construct at day 7. (B) Image of a 1 cm x 1 cm, self-assembled 3D tissue construct
at day 7. (C) Representative F-Actin staining of the middle xy-plane of a macroscale 3D tissue construct shows oriented
actin fiber organization in a single direction.
Figure 15. Schematic of the experimental setup. ESC-derived cardiomyocytes were plated on a chamber slide. The
white LED and pinhole combination was used as a light source for imaging the beating cardiomyocytes. The real-time
beating rates of the cardiomyocytes were measured using the CMOS imaging module which was controlled by an im‐
age processing program. Reproduced by permission of The Royal Society of Chemistry.
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[36, 37]. An increasing isoprenaline concentration resulted in an increase in the beat-to-beat
variation (Figure 17D).
Figure 17. Chronotropic effects of cardiomyocytes under treatment of different concentrations of isoprenaline (1, 5,
10 and 100 nM). (A) The change in beating rate. The beating rates increased after isoprenaline injection. (B) A plot of
the image difference value. A pulse pattern was observed. The decreased beating intervals were observed clearly after
isoprenaline was injected. (C) The change in beating rates over time during the first 12 min after treatment of isopre‐
naline. (D) The beat-to-beat variations. Beat-to-beat variations increased under treatment of isoprenaline. * shows a
significant difference in variance (p < 0.05). For statistical analysis, one-way ANOVA was used. Reproduced by permis‐
sion of The Royal Society of Chemistry.
As expected for doxorubicin, exposure to the drug slowed beating rates in a time dependent
manner (Figure 18A). Again, the drug was dissolved in culture medium at various concentra‐
tions (10, 100, 200 and 300 μM) and added to the chamber slide. The measurements were
Figure 16. Characterization of the lensfree cardiotoxicity detector. Prior to injection of the drugs, the ESC-derived car‐
diomyocytes were cultured in normal medium and their beating rates were observed for 150 min. The beating rates
were stable and the beating signal had a regular pulse pattern. Reproduced by permission of The Royal Society of
Chemistry.
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collected consecutively for 30s for a period of 5 min. The higher concentrations (200 and 300
μM) of doxorubicin resulted in a rapid decrease in the beating rate, and the beating stopped
after 20 min for the highest concentration. The effects were much slower for the lower
concentrations, however, a decrease in beating rate was still observed. The pulse pattern
slowed as the interval between the spikes became longer (Figure 18B) indicating a decrease in
the beating rates. A change in amplitude was also apparent, however, our imaging processing
program did not contain an amplitude detection algorithm, and the apparent decrease could
be contributed to a small difference between the reference and the live frame images. At 100
min, the beat rates as a function of doxorubicin concentration were compared and are shown
in Figure 18C. A statistical difference was observed at 100 and 200 μM doxorubicin with the
beating rates decreasing 26% and 54%, respectively. We also measured the beat-to-beat
variations induced by the different doxorubicin concentrations (Figure 18D). The response
time of the beat-to-beat variations was slower than observed for the change in beating rates.
These findings are consistent with electrical measurements from a previous study [38].
Following injection of the doxorubicin, the beating of the ESC-derived cardiomyocytes became
more irregular than was observed in the presence of isoprenaline.
Figure 18. Chronotropic effects of cardiomyocytes under treatment with doxorubicin (10, 100, 200 and 300 µM). (A)
The change in beating rate. The beating rates decreased after doxorubicin injection. (B) The beating signal. The in‐
creased beating intervals were clearly observed after doxorubicin injection. (C) The change in beating rates at 100 min
after the treatment with doxorubicin. (D) The beat-to-beat variations. In contrast to beating rates, the beat-to-beat
variations increased after treatment with doxorubicin. * shows a significant difference in variance (p < 0.05). For statis‐
tical analysis, one-way ANOVA was used. Reproduced by permission of The Royal Society of Chemistry.
The development of a cell-based biosensor using an off-the-shelf CMOS system represents a
low-cost, relatively straight forward system that can be useful in monitoring the physiological
response of cells to a drug or contaminant. We envision the expansion of this platform to harbor
complex matrices of cells that recapitulate major organ systems and respond to toxicity via
different modes of action.
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Our collaborative efforts with Dr. Robert Langer at the Massachusetts Institute of Technology
have yielded the development of sacrificial melt-spun interconnected microfibers as an
artificial vascular system [39, 40]. The system is based on the initial experiments by Bellan, et
al. that used standard sugar-based cotton candy to create an interconnected 3D microchannel
network inside several materials, including polydimethylsiloxane (PDMS), epoxy, and
polycaprolactone (PCL) [39]. Briefly, the microchannel network of cotton candy (attached to
larger sticks of sugar in order to produce macrochannel interfaces) was embedded within the
material of choice, which was then allowed to solidify. The embedded sugar fibers were
dissolved by submerging the structure in a warm water bath, leaving behind a 3D microchan‐
nel network in the shape of the cotton candy. The resulting device supported flow of a solution
of either 2 μm polystyrene spheres or heparinized whole rat blood. The channel sizes and
spacing between channels were very similar to the relevant parameters for natural capillary
beds thus providing an excellent means to replicate the cardiovascular network.
We next evolved the microvasculature network into a more complex 3D structure with the
integration of  larger,  lithographically  patterned microchannels  [40].  This  3D structure  is
composed of a melt-spun sugar microfiber network “sandwiched” between a top and bottom
lithographically patterned microfluidic system, and the fabrication process is  detailed in
Figure 19. A comparison of the filling ability was made between our hybrid device and a
device with the lithographically patterned channel system connected by simple, vertical pipes.
Both were filled with a fluorescent dye solution to visualize the extent of delivery into the
device volume (Figure 20). Fluorescent dye was carried only to localized regions within the
device lacking the 3D microfluidic network (Figure 20B). However, fluorescence was observed
throughout the device volume for the hybrid device containing the microfluidic network
(Figures 20C, 20D, and 20E). This indicated that the microfluidic network was well distribut‐
ed throughout the device and thus greatly increased the channel surface area. We achieved
an  approximate  five-fold  increase  in  total  volume  addressed  with  the  inclusion  of  the
microfluidic  network  between  the  larger,  lithographically  patterned  channel  systems.
Consequently, with this increased surface area comes an order of magnitude increase in the
measured flow resistance ranging from 12-27 psi min mL-1 compared to the device lacking
the microfluidic network (~0.5 psi min mL-1).  The drastic difference can be explained by
comparing the cross-sectional area of the smallest channels of the two devices. The conven‐
tional device contains channels with the smallest cross-section of 100 μm x 50 μm, while
hybrid channels are much smaller at approximately 10 μm, which is similar to a natural
capillary. We also observed some device-to-device variations in the flow patterns due to the
differences in the volume of  sacrificial  material,  the fiber density,  and the interfaces be‐
tween the fiber network and the larger lithographic pattern. Nevertheless, a hybrid device
with a combination of conventional planar microfluidics and a 3D microchannel network
may provide the best option to deliver the highest volume of nutrients and oxygen to an
embedded cell population while maintaining the desired channel density and interconnectiv‐
ity.
We envision a hybrid device such as this containing a capillary bed-like vasculature to be a
valuable tool for tissue engineering applications involving cell embedded scaffolds or
biomaterials as a means to exchange oxygen and nutrients, remove waste products, and
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Figure 19. Illustration of hybrid device assembly process. A) A conapoxy mold is patterned from a silicone master. B)
The conapoxy mold is coated with a thin layer of sugar. C) A melt-spun sugar microfiber network is adhered to the
sugar layer on the conapoxy mold. D) A second sugar-coated conapoxy mold is placed on top of the microfiber net‐
work. E) The space between the two conapoxy molds is infiltrated with uncured PDMS. F) When the PDMS has cured,
the conapoxy molds are removed. G) The device is placed in a water bath to remove all sugar structures. H) The top
and bottom of the channel system are sealed using flat slabs of PDMS.
Figure 20. A) Illustration of hybrid device architecture, showing two lithographically patterned channel systems
(green) connected by a 3D microfluidic network (blue) formed with sacrificial microfibers. B-D) Fluorescence microsco‐
py images of cross-sections of devices that have been exposed to Rhodamine B dye for 45 minutes. B) A conventional
two-layer microfluidic device. C) A hybrid microfluidic device containing both conventionally patterned channels and a
microfiber-formed 3D channel network. D,E) Higher magnification images of a hybrid device.
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reproduce the in vivo flow properties to achieve a physiologically realistic organ mimic. This
method is rapid, inexpensive, easily scalable, and requires no toxic materials and therefore
enables significant advancements in biomaterials and cell-based biosensor development.
However, to produce fully biomimetic scaffolds, it must eventually be adapted for use with
hydrogels and we have already made significant progress in this arena.
In collaboration with Dr. Michael Shuler’s laboratory at Cornell University, we have developed
a micro cell culture analog (μCCA) with 3D hydrogel-cell cultures that reproduces multi-organ
interactions and enables chemical toxicity studies in a more physiologically relevant environ‐
ment [41, 42]. Specific organ cell-hydrogel cultures (liver, marrow, or tumor) are maintained
as discrete populations but are connected by channels mimicking blood flow within the device.
The fluidic pattern of channels is precisely calculated so that upon fabrication of the chip, the
resulting fluid flow mimics the properties of circulating blood. From previous studies, the
μCCA was used to observe the physiological effects of naphthalene, doxorubicin, and Tegafur,
which all have metabolism-dependent toxicity effects in the body [7, 41, 43]. This microfluidic
network enables an accurate physical representation of pharmacokinetic-pharmacodynamic
(PK-PD) models for PK profile studies of a compound (e.g., toxicant, pharmaceutical, drug
candidate, etc.) [44]. The body’s organ systems are accurately represented as individual
compartments connected by a “vascular system” of networked fluidic channels. This physical
tool allows for the testing of the PK mathematical modeling that predicts the concentration
and metabolite profiles of a drug from a given dose [45]. In contrast to PK, the PD of a
compound relates to the pharmacological effect of that substance at a given concentration. The
time course of pharmacological effects of a substance (at one concentration) can be predicted
by combining the PK and PD models [46]. Our advancements of the μCCA have integrated a
microfluidic system and a PK-PD modeling approach into an in vitro/in silico system that allows
for the comparison of physical effects and mathematical predictions in order to generate a more
realistic prediction of the toxicity or efficacy of a drug compound (Figure 21) [47].
The multilayered μCCA device is assembled between an aluminum frame and a plexiglass top
that seals the PDMS layer that contain the fluidic channel features to a silicon gasket (0.2 mm
thick) with cell culture reservoirs (Figure 21A). A polycarbonate base and an additional silicone
gasket (0.5 mm thick) are also included to improve sealing of the device. The PDMS fluidic
channels mimic the distributed blood flow volume observed in vivo for the organ systems
represented on the μCCA device: liver (58%), tumor (18%) and marrow (24%) as determined
by the PBPK model (Figure 21B) [41, 48]. The cell lines chosen are HepG2-C3A (liver), HCT-116
(colon cancer tumor), myeloblasts Kasumi-1 (marrow), and each population is encapsulated
its own hydrogel matrix (alginate or Matrigel™). Figure 21C shows the assembled device.
As an alternative to a peristaltic pump-induced recirculation [41], we adapted the μCCA
system to be a pumpless device that functions using gravity-induced flow (Figure 22A) [42].
The pumpless operation eliminates troublesome bubbles that can form and get trapped within
the device channels due to use of a peristaltic pump. As shown in Figure 22B, the flow rate is
linearly proportional to the height difference. However, the finite size of the reservoir likely
explains why the line does not extrapolate to zero. In assembled, rocking μCCA devices, cell
survivability was maintained for at least three days without replacement of the medium, but
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viability was extended for a longer time (5 days) with regular changes of medium. For testing,
the device was placed on a rocking platform with a directional change occurring every three
minutes. The desired concentrations of the drug compound tested, 5-fluorouracil (5-FU) with/
without uracil, was added to the cell culture medium, and after the determined exposure time,
the device was disassembled for viability staining of the cells (details given in [42]).
Figure 22. (a) Medium recirculation with gravity-induced flow in a mCCA. Tilting of the device causes liquid to flow
from one well to the other well. In about 3 min, the rocking platform changes the angle and medium flows in the
opposite direction. (b) A plot of measured flow rates against various heights. Reproduced by permission of The Royal
Society of Chemistry.
The chosen cells (liver, tumor and marrow), encapsulated in a hydrogel matrix (alginate or
Matrigel), were tested following a three day exposure to 5-FU (0.1 mM) in the presence or
Figure 21. (a) A schematic of device components. A fluidic channel layer and a cell culture chamber layer are superim‐
posed and sealed by top and bottom frames. A silicone gasket and a polycarbonate base are inserted for sealing. (b) A
corresponding PBPK model, with the liver, tumor and marrow compartment. Below is a PD model for cell death in
each compartment. Although not drawn explicitly, a PD model for each compartment exists separately, and the ‘or‐
gan’ can be the liver, tumor or marrow. (c) A picture of the assembled device. A red dye was used for visualization of
channels, and a blue dye was mixed with the alginate. Reproduced by permission of The Royal Society of Chemistry.
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absence of uracil (0.5 mM) (Figure 23). The metabolism of 5-FU, a chemotherapeutic, is
inhibited by uracil due to competition for the enzyme (DPD) that primarily metabolizes 5-FU
[49, 50]. The addition of uracil allows more 5-FU to remain, and since 5-FU is toxic to cells over
time, this combination should prove more toxic to the cell populations. In the case of cells
encapsulated in alginate, the viabilities were not statistically different (Figure 23A). However,
for the Matrigel-encapsulated cells, the tumor and marrow cells showed a significant decrease
in viability with the addition of uracil (Figure 23B). Although both hydrogels are biologically
compatible, they likely have different effects on the metabolic activity of the embedded cells.
Cells do not readily attach to and remodel alginate because it is a negatively charged polymer,
lacking functional groups that facilitate cell signaling and functioning [51]. Matrigel, a protein
mixture secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells, may be more
suitable for eukaryotic cells to maintain their functionality and thus their toxicity response, as
reported for hepatocytes [52, 53]. This may explain the viability differences we observed
between the hydrogels for the cell lines tested, and this remains an area of active research.
Figure 23. (a) Viability of three cell lines after 3-day treatment with 5-FU alone or 5-FU plus uracil (U) in a µCCA, en‐
capsulated in 2% alginate. (b) Viability of three cell lines after 3-day treatment with 5-FU alone or 5-FU plus uracil (U).
Cells were encapsulated in Matrigel™ in a µCCA. Reproduced by permission of The Royal Society of Chemistry.
The simplification of this rocking μCCA system lessens the requirement for specialized
techniques for assembly and operation often an issue with microfluidics. We have preserved
the ability to perform pharmacokinetic-based toxicity testing on multiple cell types as 3D cell-
hydrogel cultures. Further, our research indicates that the physical assembly of the biosensor
can be performed without significant cell damage. This supports the use of this type of cell-
based biosensor for the use in toxicity monitoring applications.
4. Conclusions
We believe that the work detailed in the above sections provides key technologies and tools
that bring us closer to the realization of a total “body on a chip” for applications ranging from
pharmaceutical testing of drug candidates to fieldable devices that are capable of physiologi‐
cally accurate toxicity responses. Additionally, the technologies developed are pursuant
toward increasing the cell lifetime and survivability in the biosensor constructs. Since our focus
is on military applications, a robust toxicity microanalysis system has innumerable potential
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uses for the soldier including toxicity devices for water resources in harsh environments,
monitoring at military installations to ensure environmental sustainability, rapid screening of
drinking water, and enhanced decision processing for military bases.
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